Annual accounts receivable:
$8.19B-$30.00M(-0.36%)Summary
- As of today (May 29, 2025), TMO annual accounts receivable is $8.19 billion, with the most recent change of -$30.00 million (-0.36%) on December 31, 2024.
- During the last 3 years, TMO annual accounts receivable has risen by +$214.00 million (+2.68%).
- TMO annual accounts receivable is now -0.36% below its all-time high of $8.22 billion, reached on December 31, 2023.
Performance
TMO Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$8.46B+$264.00M(+3.22%)Summary
- As of today (May 29, 2025), TMO quarterly accounts receivable is $8.46 billion, with the most recent change of +$264.00 million (+3.22%) on March 29, 2025.
- Over the past year, TMO quarterly accounts receivable has increased by +$524.00 million (+6.61%).
- TMO quarterly accounts receivable is now at all-time high.
Performance
TMO Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TMO Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.4% | +6.6% |
| 3 y3 years | +2.7% | +7.2% |
| 5 y5 years | +88.3% | +87.6% |
TMO Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.4% | +2.7% | at high | +10.2% |
| 5 y | 5-year | -0.4% | +88.3% | at high | +88.8% |
| alltime | all time | -0.4% | +1893.1% | at high | +2026.5% |
TMO Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $8.46B(+3.2%) |
| Dec 2024 | $8.19B(-0.4%) | $8.19B(-0.8%) |
| Sep 2024 | - | $8.26B(+3.9%) |
| Jun 2024 | - | $7.94B(+0.2%) |
| Mar 2024 | - | $7.93B(-3.5%) |
| Dec 2023 | $8.22B(+1.3%) | $8.22B(-1.8%) |
| Sep 2023 | - | $8.37B(+4.4%) |
| Jun 2023 | - | $8.02B(+1.2%) |
| Mar 2023 | - | $7.92B(-2.4%) |
| Dec 2022 | $8.12B(+1.7%) | $8.12B(+5.8%) |
| Sep 2022 | - | $7.67B(-1.0%) |
| Jun 2022 | - | $7.75B(-1.8%) |
| Mar 2022 | - | $7.89B(-1.1%) |
| Dec 2021 | $7.98B(+38.9%) | $7.98B(+43.5%) |
| Sep 2021 | - | $5.56B(+1.5%) |
| Jun 2021 | - | $5.48B(-1.4%) |
| Mar 2021 | - | $5.55B(-3.3%) |
| Dec 2020 | $5.74B(+32.0%) | $5.74B(+10.7%) |
| Sep 2020 | - | $5.19B(+15.8%) |
| Jun 2020 | - | $4.48B(-0.7%) |
| Mar 2020 | - | $4.51B(+3.7%) |
| Dec 2019 | $4.35B(+5.1%) | $4.35B(-0.8%) |
| Sep 2019 | - | $4.38B(+6.2%) |
| Jun 2019 | - | $4.13B(-0.6%) |
| Mar 2019 | - | $4.16B(+0.5%) |
| Dec 2018 | $4.14B(+6.6%) | $4.14B(+7.4%) |
| Sep 2018 | - | $3.85B(-1.5%) |
| Jun 2018 | - | $3.91B(-2.0%) |
| Mar 2018 | - | $3.99B(+2.9%) |
| Dec 2017 | $3.88B(+27.2%) | $3.88B(+6.1%) |
| Sep 2017 | - | $3.66B(+12.2%) |
| Jun 2017 | - | $3.26B(+5.2%) |
| Mar 2017 | - | $3.10B(+1.6%) |
| Dec 2016 | $3.05B(+19.8%) | $3.05B(+5.3%) |
| Sep 2016 | - | $2.90B(+6.9%) |
| Jun 2016 | - | $2.71B(+1.5%) |
| Mar 2016 | - | $2.67B(+4.8%) |
| Dec 2015 | $2.54B(+2.9%) | $2.54B(+0.0%) |
| Sep 2015 | - | $2.54B(-3.3%) |
| Jun 2015 | - | $2.63B(+3.7%) |
| Mar 2015 | - | $2.54B(+2.6%) |
| Dec 2014 | $2.47B(+27.4%) | $2.47B(-1.3%) |
| Sep 2014 | - | $2.51B(-5.8%) |
| Jun 2014 | - | $2.66B(-1.3%) |
| Mar 2014 | - | $2.70B(+38.8%) |
| Dec 2013 | $1.94B | $1.94B(-0.1%) |
| Sep 2013 | - | $1.95B(+2.3%) |
| Jun 2013 | - | $1.90B(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $1.90B(+5.5%) |
| Dec 2012 | $1.80B(+2.3%) | $1.80B(-1.3%) |
| Sep 2012 | - | $1.83B(+1.4%) |
| Jun 2012 | - | $1.80B(-4.8%) |
| Mar 2012 | - | $1.89B(+7.4%) |
| Dec 2011 | $1.76B(+19.7%) | $1.76B(-2.6%) |
| Sep 2011 | - | $1.81B(+7.6%) |
| Jun 2011 | - | $1.68B(+7.5%) |
| Mar 2011 | - | $1.57B(+6.2%) |
| Dec 2010 | $1.47B(+4.6%) | $1.47B(+0.1%) |
| Jun 2010 | - | $1.47B(-1.4%) |
| Mar 2010 | - | $1.49B(+6.0%) |
| Dec 2009 | $1.41B(-4.6%) | $1.41B(-4.9%) |
| Sep 2009 | - | $1.48B(+0.8%) |
| Jun 2009 | - | $1.47B(+3.3%) |
| Mar 2009 | - | $1.42B(-3.7%) |
| Dec 2008 | $1.48B(+1.9%) | $1.48B(-4.2%) |
| Sep 2008 | - | $1.54B(-3.5%) |
| Jun 2008 | - | $1.60B(+0.8%) |
| Mar 2008 | - | $1.59B(+9.4%) |
| Dec 2007 | $1.45B(+4.1%) | $1.45B(-0.6%) |
| Sep 2007 | - | $1.46B(+2.5%) |
| Jun 2007 | - | $1.42B(+0.2%) |
| Mar 2007 | - | $1.42B(+1.9%) |
| Dec 2006 | $1.39B(+148.6%) | $1.39B(+158.0%) |
| Sep 2006 | - | $539.84M(-0.9%) |
| Jun 2006 | - | $544.52M(+0.3%) |
| Mar 2006 | - | $542.93M(-3.1%) |
| Dec 2005 | $560.17M(+19.3%) | $560.17M(+7.4%) |
| Sep 2005 | - | $521.38M(+1.7%) |
| Jun 2005 | - | $512.65M(+11.8%) |
| Mar 2005 | - | $458.56M(-2.3%) |
| Dec 2004 | $469.55M(+11.9%) | $469.55M(+9.4%) |
| Sep 2004 | - | $429.39M(+3.6%) |
| Jun 2004 | - | $414.37M(-9.6%) |
| Mar 2004 | - | $458.13M(+9.2%) |
| Dec 2003 | $419.63M(-2.4%) | $419.63M(-1.0%) |
| Sep 2003 | - | $423.94M(+4.5%) |
| Jun 2003 | - | $405.60M(-1.7%) |
| Mar 2003 | - | $412.41M(-4.0%) |
| Dec 2002 | $429.74M(+4.6%) | $429.74M(+3.9%) |
| Sep 2002 | - | $413.73M(+0.6%) |
| Jun 2002 | - | $411.15M(+3.4%) |
| Mar 2002 | - | $397.61M(-3.2%) |
| Dec 2001 | $410.96M(-8.7%) | $410.96M(-0.3%) |
| Sep 2001 | - | $412.35M(+1.7%) |
| Jun 2001 | - | $405.53M(-5.4%) |
| Mar 2001 | - | $428.46M(-4.8%) |
| Dec 2000 | $450.00M | $450.00M |
FAQ
- What is Thermo Fisher Scientific annual accounts receivable?
- What is the all time high annual accounts receivable for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific annual accounts receivable year-on-year change?
- What is Thermo Fisher Scientific quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific quarterly accounts receivable year-on-year change?
What is Thermo Fisher Scientific annual accounts receivable?
The current annual accounts receivable of TMO is $8.19B
What is the all time high annual accounts receivable for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high annual accounts receivable is $8.22B
What is Thermo Fisher Scientific annual accounts receivable year-on-year change?
Over the past year, TMO annual accounts receivable has changed by -$30.00M (-0.36%)
What is Thermo Fisher Scientific quarterly accounts receivable?
The current quarterly accounts receivable of TMO is $8.46B
What is the all time high quarterly accounts receivable for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high quarterly accounts receivable is $8.46B
What is Thermo Fisher Scientific quarterly accounts receivable year-on-year change?
Over the past year, TMO quarterly accounts receivable has changed by +$524.00M (+6.61%)